Maiter D, Underwood L E, Martin J B, Koenig J I
Department of Neurology, Massachusetts General Hospital, Boston.
Endocrinology. 1991 Feb;128(2):1100-6. doi: 10.1210/endo-128-2-1100.
Administration of monosodium glutamate (MSG) to neonatal rodents produces permanent lesions of hypothalamic arcuate neurons that secrete GH-releasing hormone (GHRH). The present study was intended to determine the consequences of GHRH deficiency on the pulsatile GH secretory pattern and growth in MSG-treated female rats and to compare these effects with those observed in male littermates. Male and female rats were injected with MSG [4 mg/g body wt (BW), sc] or saline (controls) on days 2, 4, 6, 8, and 10 after birth. Immunoreactive GHRH concentrations were decreased in the hypothalamus (by 60%) and in the median eminence (by 95%) of adult male and female MSG-treated rats. In contrast, somatostatin concentrations were unaffected. BW and linear growth were severely impaired in male MSG-treated rats, but in MSG-lesioned females BW was not different from controls, and the attenuation of longitudinal growth was less severe and the obesity more pronounced than in males. These sex differences occurred despite similar reductions (by 55%) in serum insulin-like growth factor I concentrations in male and female MSG-treated rats. MSG treatment also produced decreases in pituitary wt and GH content (by 60%), independent of sex. Pulsatile GH secretion was studied by serial blood sampling of chronically cannulated, freely moving rats. Plasma GH patterns were analyzed by the PULSAR program. Compared to controls, treatment with MSG led to a marked inhibition (by 90%) of GH secretion in both sexes. Significant reductions in GH pulse amplitude (-95%) and pulse duration (-62%) were observed in males, whereas pulse amplitude (-85%), pulse frequency (-67%), and baseline GH concentrations (-80%) were markedly reduced in females. The GH responses to an iv bolus injection of rat GHRH (1 microgram/rat) was severely blunted in both male and female MSG-treated rats. This study demonstrates that GHRH deficiency in female rats results in a marked inhibition of GH pulses, as in males, but also causes severe and sex-specific reductions in GH basal secretion and pulse frequency. These observations suggest that hypothalamic GHRH secretion in female rats is more continuous than in males and is a determinant of the elevated interpulse secretion of GH. Moreover, body wt and linear growth are less severely affected by arcuate lesions in female animals, compared to males. These sex-related differences in growth rates may result in part from the tendency of female MSG-lesioned rats to become more obese than males, and the development of obesity, in turn, may antagonize the factors that tend to slow linear growth.(ABSTRACT TRUNCATED AT 400 WORDS)
给新生啮齿动物注射味精(MSG)会导致下丘脑弓状神经元永久性损伤,这些神经元分泌生长激素释放激素(GHRH)。本研究旨在确定GHRH缺乏对经MSG处理的雌性大鼠脉冲式生长激素分泌模式和生长的影响,并将这些影响与在同窝雄性大鼠中观察到的进行比较。雄性和雌性大鼠在出生后第2、4、6、8和10天注射MSG[4mg/g体重(BW),皮下注射]或生理盐水(对照组)。成年雄性和雌性经MSG处理的大鼠下丘脑(降低60%)和正中隆起(降低95%)中免疫反应性GHRH浓度降低。相比之下,生长抑素浓度未受影响。经MSG处理的雄性大鼠体重和线性生长严重受损,但经MSG损伤的雌性大鼠体重与对照组无差异,纵向生长的减弱程度较轻,肥胖比雄性更明显。尽管雄性和雌性经MSG处理的大鼠血清胰岛素样生长因子I浓度均有类似程度的降低(55%),但仍出现了这些性别差异。MSG处理还导致垂体重量和生长激素含量降低(60%),与性别无关。通过对长期插管、自由活动的大鼠进行连续采血来研究脉冲式生长激素分泌。血浆生长激素模式通过PULSAR程序进行分析。与对照组相比,MSG处理导致两性生长激素分泌均受到显著抑制(90%)。在雄性大鼠中观察到生长激素脉冲幅度(-95%)和脉冲持续时间(-62%)显著降低,而在雌性大鼠中脉冲幅度(-85%)、脉冲频率(-67%)和基础生长激素浓度(-80%)显著降低。在雄性和雌性经MSG处理的大鼠中,静脉注射大鼠GHRH(1μg/只)后的生长激素反应均严重减弱。本研究表明,雌性大鼠GHRH缺乏与雄性一样会导致生长激素脉冲显著抑制,但也会导致生长激素基础分泌和脉冲频率出现严重的性别特异性降低。这些观察结果表明,雌性大鼠下丘脑GHRH分泌比雄性更持续,是生长激素脉冲间期分泌升高的一个决定因素。此外,与雄性相比,雌性动物弓状核损伤对体重和线性生长的影响较小。这些生长速度方面与性别相关的差异可能部分源于经MSG损伤的雌性大鼠比雄性更容易肥胖,而肥胖的发展反过来可能会对抗那些倾向于减缓线性生长的因素。(摘要截短至400字)